ArticleAmerican journal of cancer research2025

Neuropilin-2 (NRP2) mediates sorafenib resistance in clear cell renal cell carcinoma via the NRP2/NF-κB/TNFα axis.

Ruichen Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.